Opus Point Partners Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $235K | Buy |
862
+28
| +3% | +$7.63K | 0.42% | 49 |
|
|
2019
Q2 | $445K | Buy |
834
+147
| +21% | +$78.4K | 0.66% | 40 |
|
|
2019
Q1 | $346K | Sell |
687
-195
| -22% | -$98.2K | 0.47% | 50 |
|
|
2018
Q4 | $435K | Buy |
882
+95
| +12% | +$46.9K | 0.96% | 18 |
|
|
2018
Q3 | $720K | Buy |
787
+218
| +38% | +$199K | 1.72% | 23 |
|
|
2018
Q2 | $417K | Sell |
569
-993
| -64% | -$728K | 0.9% | 29 |
|
|
2018
Q1 | $2.49M | Sell |
1,562
-4,576
| -75% | -$7.29M | 4.88% | 2 |
|
|
2017
Q4 | $5.5M | Sell |
6,138
-817
| -12% | -$732K | 4.76% | 4 |
|
|
2017
Q3 | $2.5M | Buy |
6,955
+475
| +7% | +$171K | 2.25% | 10 |
|
|
2017
Q2 | $1.9M | Sell |
6,480
-5,939
| -48% | -$1.74M | 1.74% | 17 |
|
|
2017
Q1 | $4.37M | Buy |
12,419
+130
| +1% | +$45.8K | 3.25% | 8 |
|
|
2016
Q4 | $2.26M | Buy |
12,289
+515
| +4% | +$94.8K | 1.8% | 25 |
|
|
2016
Q3 | $3.03M | Sell |
11,774
-128
| -1% | -$33K | 1.7% | 15 |
|
|
2016
Q2 | $2.54M | Sell |
11,902
-7,309
| -38% | -$1.56M | 2.45% | 16 |
|
|
2016
Q1 | $3.96M | Sell |
19,211
-4,028
| -17% | -$831K | 3.06% | 8 |
|
|
2015
Q4 | $5.87M | Sell |
23,239
-6,378
| -22% | -$1.61M | 3.88% | 5 |
|
|
2015
Q3 | $4.87M | Buy |
29,617
+5,086
| +21% | +$836K | 2.69% | 11 |
|
|
2015
Q2 | $4.6M | Buy |
24,531
+2,154
| +10% | +$404K | 3.65% | 7 |
|
|
2015
Q1 | $3.69M | Buy |
22,377
+6,570
| +42% | +$1.08M | 3.09% | 17 |
|
|
2014
Q4 | $3.68M | Buy |
+15,807
| New | +$3.68M | 3.64% | 6 |
|